Marc Grasso - Jun 30, 2025 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role: Chief Financial Officer
Signature: By: /s/ Samantha H. Eldredge, as Attorney-in-Fact
Stock symbol: KYTX
Transactions as of: Jun 30, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/1/2025, 08:28 PM
Previous filing: Jun 4, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GRASSO MARC	Chief Financial Officer	C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE	By: /s/ Samantha H. Eldredge, as Attorney-in-Fact	2025-07-01	0001748894

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYTX	Stock Option (right to buy)	Award	$0	-450K	-50%	$0.00	450K	Jun 30, 2025	Common Stock	450K	$3.07	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option shall vest on June 30, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.